Search results
Q1 2024 Nektar Therapeutics Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 29 minutes agoThere are approximately 30 million people in the US alone living with atopic dermatitis and half of these patients are diagnosed with moderate to severe ...
BofA bullish on Apogee stock, sees significant market growth potential By Investing.com
Investing.com· 1 hour agoFriday, BofA Securities initiated coverage on Apogee (NASDAQ:APOG) Therapeutics Inc (NASDAQ:APGE)...
...Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual...
Benzinga· 3 days agoThe KOL event, "Treatment Options for Atopic Dermatitis Patients with an Inadequate Response to Dupilumab: Exploring the Potential of ...
New treatment could reverse hair loss caused by autoimmune skin disease alopecia areata
Medical Xpress· 1 day agoThe team has developed a microneedle patch that can be painlessly applied to the scalp and releases...
Warner Bros. upgraded, Cerence downgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 1 hour agoBofA initiated coverage of Apogee Therapeutics (APGE) with a Buy rating and $80 price target. The...
Aclaris Therapeutics Inc (ACRS) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
GuruFocus.com via Yahoo Finance· 2 days agoThere are inherent risks in drug development, highlighted by the need for reevaluation of ATI 2138's indication selection, which can lead to delays and increased costs. The competitive landscape ...
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoAclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript May 7, 2024 Aclaris...
Here are Friday's biggest analyst calls of the day: Nvidia, Tesla, Apple, 3M, Bumble, Nike, Walmart,...
CNBC· 2 hours agoHere are the biggest calls on Wall Street on Friday: Bernstein reiterates Nvidia as outperform...
Managing Comorbidities in Chronic Urticaria
MedPage Today· 1 day agoThe link between chronic urticaria and atopic diseases, autoimmune diseases, and psychiatric disorders has significant implications for clinical practice. Managing comorbidities ...
Q1 2024 Corvus Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 days agoAnd third, it may have broad utility across many different autoimmune and inflammatory diseases, and this trial may provide proof of concept for the treatment of other immune ...
